Korro Bio, Inc. (KRRO)
NASDAQ·Healthcare·Biotechnology
$11.47
+8.93%
Mkt Cap $115.83M
Analyst Ratings
No recent rating data.
Price Target (15 analysts)
$19.57
Range $10.00 – $30.00
Implied Upside
+70.6%
Consensus $19.57 vs current $11.47
NASDAQ·Healthcare·Biotechnology
$11.47
+8.93%
Mkt Cap $115.83M
No recent rating data.
Price Target (15 analysts)
$19.57
Range $10.00 – $30.00
+70.6%
Consensus $19.57 vs current $11.47